A detailed history of C M Bidwell & Associates LTD transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 316 shares of PACB stock, worth $609. This represents 0.0% of its overall portfolio holdings.

Number of Shares
316
Previous 316 -0.0%
Holding current value
$609
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$5.67 - $11.2 $1,247 - $2,464
220 Added 229.17%
316 $2,000
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $377 - $822
96 New
96 $1,000
Q2 2022

Aug 12, 2022

SELL
$4.02 - $10.43 $385 - $1,001
-96 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$8.43 - $20.9 $809 - $2,006
96 New
96 $1,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $434M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.